Kenneth W. O'Keefe, Director at Jazz Pharmaceuticals plc (JAZZ), sold 22,000 shares at $152.57 ($3.4M) on 2020-11-05, disclosed to the SEC on 2020-11-09.
Open-market sale of $3.4M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.57 | 2,001 | $305K | 9.0% |
| 2 | $152.57 | 2,001 | $305K | 9.0% |
| 3 | $153.74 | 2,740 | $421K | 12.4% |
| 4 | $153.74 | 2,740 | $421K | 12.4% |
| 5 | $155.14 | 1,746 | $271K | 8.0% |
| 6 | $155.14 | 1,746 |
| $271K |
| 8.0% |
| 7 | $156.44 | 4,513 | $706K | 20.7% |
| 8 | $156.44 | 4,513 | $706K | 20.7% |
| Total | $154.86 avg | 22,000 | $3.4M | 100% |
| Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |
| JAZZ | SELL | 2020-08-10 | $234K | — | Filing → |